Founded: 1981
Officers: Dale Taylor: President & CEO, dtaylor@abelsontaylor.com
Jay Carter: Senior VP, Director of Strategy Services, jcarter@abelsontaylor.com
Nancy Drescher: Senior VP, Director of Client Services, ndrescher@abelsontaylor.com
Stephen Neale: Senior VP, Executive Creative Director: sneale@abelsontaylor.com
Keith Stenlund: VP, CFO, stenlund@abelsontaylor.com
Laura Bartmess: VP, Account Director, lbartmess@abelsontaylor.com
Jeff Berg: VP, Account Director, jberg@abelsontaylor.com
Beth Hall: VP of Support Services, bhall@abelsontaylor.com
Scott Hansen: VP, Creative Group Director, shansen@abelsontaylor.com
Rob Kienle: VP, Director of Copy Strategy, rkienle@abelsontaylor.com
Jeanine Koch: VP, Account Director, jkoch@abelsontaylor.com
Angela Lustig: VP, Creative Group Director, alustig@abelsontaylor.com
Allan Mills: VP, Account Director, amills@abelsontaylor.com
Greg Niemczyk: VP, Account Director, gniemczyk@abelsontaylor.com
Mike Perry: VP, Account Director, mperry@abelsontaylor.com
Elizabeth Rambach: VP, Account Director, erambach@abelsontaylor.com
Cindy Stone: VP, Account Director, cstone@abelsontaylor.com
Josh Vizek: VP, Creative Group Director, jvizek@abelsontaylor.com
Greg Thompson, MD: VP, Medical Director, gthompson@abelsontaylor.com
Matt Collins, Director of Integrated Development, mcollins@abelsontaylor.com
Tristen George: Creative Director, tgeorge@abelsontaylor.com
Janet Kleve, Creative Director, jkleve@abelsontaylor.com
Barry Levine: Creative Director, blevine@abelsontaylor.com
Noah Lowenthal: Creative Director, nlowenthal@abelsontaylor.com
Ed St. Peter: Director of Integrated Production, estpeter@abelsontaylor.com
Jody Van Swearingen: Creative Director, jvanswearingen@abelsontaylor.com.
2010 Gross Income: $65 million to $100 million.
Full-time Employees: 403 (2010) 394 (2009)
Healthcare accounts: Abbott Nutrition : Enlive, Ensure, Glucerna, Juven, Pedialyte, PediaSure, Sensiva, Similac, Survanta;
Abbott Pharmaceutical Product Division : ABT-888 (Veliparib), AndroGel, Kaletra, Lupron Franchise, Niaspan, Prometrium, Simcor, TriCor, Trilipix; ;
Astellas : AmBisome, MYCAMINE;
Astellas/GSK : VESIcare;
Astellas/Theravance : Vibativ;
Cadence Pharmaceuticals : Ofirmev;
Cell Therapeutics : Pixuvri;
Cornerstone Therapeutics : Curosurf, Factive;
Daiichi Sankyo : AZOR, Benicar; Tribenzor; Eisai: Banzel;
Inspiration Biopharmaceuticals : IB1001;
Kinetic Concepts : VAC and Prevena lines of negative pressure products;
MPI Research : Preclinical CRO;
Questcor : H.P. Acthar Gel;
Roche : Tarceva;
Sunovion Pharma : Latuda;
Takeda : Actos, Actoplus Met, Actosplus Met XR, Alogliptin, Alogliptin/Actos, Duetact, Kapidex; ;
Ther-Rx M: Clindesse, Evamist, Evamist, Gynazole-1, Makena;
Vein Clinics of America : Promotion of medical clinics;
Vertex : Incivek.
Number of Accounts Gained: 17
Details of Accounts Gained in 2010: Abbot Pharma Product Division : Niaspan, Kaletra, Trilipix/TriCor, SIMCOR, ABT-888, AndroGel;
Astellas : AmBisome, MYCAMINE;
Inspiration Bio: IB1001;
Kinetic Concepts : VAC and Prevena lines;
Takeda: Actoplus Met XR.
Number of Accounts Lost in 2010 : 2
Details of Account Lost in 2010: Amgen